299. Cystic fibrosis Clinical trials / Disease details
Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01543191 (ClinicalTrials.gov) | February 2012 | 27/2/2012 | A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis | A Phase 1 Dose-escalation Study TO Evaluate the Safety and Tolerability of PUR118 and Placebo in Subjects With CF | Cystic Fibrosis | Drug: PUR118 | Pulmatrix Inc. | Celerion | Completed | 18 Years | 55 Years | Both | 10 | Phase 1 | United Kingdom |